171 related articles for article (PubMed ID: 34002801)
1. Deleterious mutation V369M in the mouse GCGR gene causes abnormal plasma amino acid levels indicative of a possible liver-α-cell axis.
Liu Q; Lin G; Chen Y; Feng W; Xu Y; Lyu J; Yang D; Wang MW
Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34002801
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a naturally occurring mutation V368M in the human glucagon receptor and its association with metabolic disorders.
Lin G; Liu Q; Dai A; Cai X; Zhou Q; Wang X; Chen Y; Ye C; Li J; Yang D; Wang MW
Biochem J; 2020 Jul; 477(13):2581-2594. PubMed ID: 32677665
[TBL] [Abstract][Full Text] [Related]
3. Homozygous P86S mutation of the human glucagon receptor is associated with hyperglucagonemia, alpha cell hyperplasia, and islet cell tumor.
Zhou C; Dhall D; Nissen NN; Chen CR; Yu R
Pancreas; 2009 Nov; 38(8):941-6. PubMed ID: 19657311
[TBL] [Abstract][Full Text] [Related]
4. Disruption of glucagon receptor signaling causes hyperaminoacidemia exposing a possible liver-alpha-cell axis.
Galsgaard KD; Winther-Sørensen M; Ørskov C; Kissow H; Poulsen SS; Vilstrup H; Prehn C; Adamski J; Jepsen SL; Hartmann B; Hunt J; Charron MJ; Pedersen J; Wewer Albrechtsen NJ; Holst JJ
Am J Physiol Endocrinol Metab; 2018 Jan; 314(1):E93-E103. PubMed ID: 28978545
[TBL] [Abstract][Full Text] [Related]
5. Liver-specific disruption of the murine glucagon receptor produces α-cell hyperplasia: evidence for a circulating α-cell growth factor.
Longuet C; Robledo AM; Dean ED; Dai C; Ali S; McGuinness I; de Chavez V; Vuguin PM; Charron MJ; Powers AC; Drucker DJ
Diabetes; 2013 Apr; 62(4):1196-205. PubMed ID: 23160527
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic alpha cell glucagon-liver FGF21 axis regulates beta cell regeneration in a mouse model of type 2 diabetes.
Cui X; Feng J; Wei T; Zhang L; Lang S; Yang K; Yang J; Liu J; Sterr M; Lickert H; Wei R; Hong T
Diabetologia; 2023 Mar; 66(3):535-550. PubMed ID: 36331598
[TBL] [Abstract][Full Text] [Related]
7. Elevated Serum Amino Acids Induce a Subpopulation of Alpha Cells to Initiate Pancreatic Neuroendocrine Tumor Formation.
Smith DK; Kates L; Durinck S; Patel N; Stawiski EW; Kljavin N; Foreman O; Sipos B; Solloway MJ; Allan BB; Peterson AS
Cell Rep Med; 2020 Aug; 1(5):100058. PubMed ID: 33205067
[TBL] [Abstract][Full Text] [Related]
8. Glucagon acutely regulates hepatic amino acid catabolism and the effect may be disturbed by steatosis.
Winther-Sørensen M; Galsgaard KD; Santos A; Trammell SAJ; Sulek K; Kuhre RE; Pedersen J; Andersen DB; Hassing AS; Dall M; Treebak JT; Gillum MP; Torekov SS; Windeløv JA; Hunt JE; Kjeldsen SAS; Jepsen SL; Vasilopoulou CG; Knop FK; Ørskov C; Werge MP; Bisgaard HC; Eriksen PL; Vilstrup H; Gluud LL; Holst JJ; Wewer Albrechtsen NJ
Mol Metab; 2020 Dec; 42():101080. PubMed ID: 32937194
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of glucagon and glucagon-like peptide 1 receptors in mouse pancreatic alpha and beta cells in two models of alpha cell hyperplasia.
Kedees MH; Grigoryan M; Guz Y; Teitelman G
Mol Cell Endocrinol; 2009 Nov; 311(1-2):69-76. PubMed ID: 19647035
[TBL] [Abstract][Full Text] [Related]
10. Angptl4 does not control hyperglucagonemia or α-cell hyperplasia following glucagon receptor inhibition.
Okamoto H; Cavino K; Na E; Krumm E; Kim S; Stevis PE; Harp J; Murphy AJ; Yancopoulos GD; Gromada J
Proc Natl Acad Sci U S A; 2017 Mar; 114(10):2747-2752. PubMed ID: 28143927
[TBL] [Abstract][Full Text] [Related]
11. Hyperglucagonemia correlates with plasma levels of non-branched-chain amino acids in patients with liver disease independent of type 2 diabetes.
Wewer Albrechtsen NJ; Junker AE; Christensen M; Hædersdal S; Wibrand F; Lund AM; Galsgaard KD; Holst JJ; Knop FK; Vilsbøll T
Am J Physiol Gastrointest Liver Physiol; 2018 Jan; 314(1):G91-G96. PubMed ID: 28971838
[TBL] [Abstract][Full Text] [Related]
12. Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice.
Gelling RW; Du XQ; Dichmann DS; Romer J; Huang H; Cui L; Obici S; Tang B; Holst JJ; Fledelius C; Johansen PB; Rossetti L; Jelicks LA; Serup P; Nishimura E; Charron MJ
Proc Natl Acad Sci U S A; 2003 Feb; 100(3):1438-43. PubMed ID: 12552113
[TBL] [Abstract][Full Text] [Related]
13. Glucagon cell hyperplasia and neoplasia: a recently recognized endocrine receptor disease.
Sipos B; Klöppel G
Endocr Relat Cancer; 2023 Aug; 30(8):. PubMed ID: 37260318
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic beta-cell overexpression of the glucagon receptor gene results in enhanced beta-cell function and mass.
Gelling RW; Vuguin PM; Du XQ; Cui L; Rømer J; Pederson RA; Leiser M; Sørensen H; Holst JJ; Fledelius C; Johansen PB; Fleischer N; McIntosh CH; Nishimura E; Charron MJ
Am J Physiol Endocrinol Metab; 2009 Sep; 297(3):E695-707. PubMed ID: 19602585
[TBL] [Abstract][Full Text] [Related]
15. A Primary Role for α-Cells as Amino Acid Sensors.
Dean ED
Diabetes; 2020 Apr; 69(4):542-549. PubMed ID: 31653720
[TBL] [Abstract][Full Text] [Related]
16. The V369M Gcgr knock-in mice are a precision medicine model of mild Mahvash disease.
Yu R
Biochem J; 2020 Aug; 477(15):2873-2874. PubMed ID: 32785645
[TBL] [Abstract][Full Text] [Related]
17. Long-term inhibition of the glucagon receptor with a monoclonal antibody in mice causes sustained improvement in glycemic control, with reversible alpha-cell hyperplasia and hyperglucagonemia.
Gu W; Yan H; Winters KA; Komorowski R; Vonderfecht S; Atangan L; Sivits G; Hill D; Yang J; Bi V; Shen Y; Hu S; Boone T; Lindberg RA; Véniant MM
J Pharmacol Exp Ther; 2009 Dec; 331(3):871-81. PubMed ID: 19720878
[TBL] [Abstract][Full Text] [Related]
18. Glucagon and Amino Acids Are Linked in a Mutual Feedback Cycle: The Liver-α-Cell Axis.
Holst JJ; Wewer Albrechtsen NJ; Pedersen J; Knop FK
Diabetes; 2017 Feb; 66(2):235-240. PubMed ID: 28108603
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast growth factor 21 (FGF21) and glucagon-like peptide 1 contribute to diabetes resistance in glucagon receptor-deficient mice.
Omar BA; Andersen B; Hald J; Raun K; Nishimura E; Ahrén B
Diabetes; 2014 Jan; 63(1):101-10. PubMed ID: 24062250
[TBL] [Abstract][Full Text] [Related]
20. Amino Acid Transporter Slc38a5 Controls Glucagon Receptor Inhibition-Induced Pancreatic α Cell Hyperplasia in Mice.
Kim J; Okamoto H; Huang Z; Anguiano G; Chen S; Liu Q; Cavino K; Xin Y; Na E; Hamid R; Lee J; Zambrowicz B; Unger R; Murphy AJ; Xu Y; Yancopoulos GD; Li WH; Gromada J
Cell Metab; 2017 Jun; 25(6):1348-1361.e8. PubMed ID: 28591637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
